1. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020) Authors: Welsh, James; Shen, Colette; Frakes, Jessica; Niu, Jiaxin; Weiss, Jared; Caudell, Jimmy; Yun, Hu; Barsoumian, Hampartsoum; Thariat, Juliette; Bonvalot, Sylvie; Papaï, Zsusanna; Cortez, Maria Angelica; Zhang, Ping; Jameson, Katherine; Said, Patricia; Paris, Sébastien; Seiwert, Tanguy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020) Authors: Welsh, James; Shen, Colette; Frakes, Jessica; Niu, Jiaxin; Weiss, Jared; Caudell, Jimmy; Yun, Hu; Barsoumian, Hampartsoum; Thariat, Juliette; Bonvalot, Sylvie; Papaï, Zsusanna; Cortez, Maria Angelica; Zhang, Ping; Jameson, Katherine; Said, Patricia; Paris, Sébastien; Seiwert, Tanguy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors. (9th November 2020) Authors: Harrington, Kevin; Parkes, Eileen; Weiss, Jared; Ingham, Mathew; Cervantes, Andrés; Calvo, Emiliano; Riese, Matthew; Klinkhardt, Ute; Sikken, Patricia; Schmohl, Michael; Garralda, Elena Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 410 Phase I study of intratumoral NBTXR3 in combination with anti-PD-1 in patients with advanced cancers. (9th November 2020) Authors: Shen, Colette; Frakes, Jessica; Niu, Jiaxin; Weiss, Jared; Caudell, Jimmy; Jameson, Katherine; Said, Patricia; Seiwert, Tanguy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 410 Phase I study of intratumoral NBTXR3 in combination with anti-PD-1 in patients with advanced cancers. (9th November 2020) Authors: Shen, Colette; Frakes, Jessica; Niu, Jiaxin; Weiss, Jared; Caudell, Jimmy; Jameson, Katherine; Said, Patricia; Seiwert, Tanguy Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab‐paclitaxel. Issue 8 (16th August 2021) Authors: Patel, Shetal A.; Singer, Bart; Shen, Colette; Zanation, Adam M.; Yarbrough, Wendell G.; Weiss, Jared Journal: Clinical case reports Issue: Volume 9:Issue 8(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase 2 study of dalantercept, an activin receptor‐like kinase‐1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Issue 23 (20th September 2016) Authors: Jimeno, Antonio; Posner, Marshall R.; Wirth, Lori J.; Saba, Nabil F.; Cohen, Roger B.; Popa, Elizabeta C.; Argiris, Athanassios; Grossmann, Kenneth F.; Sukari, Ammar; Wilson, Dawn; Zhang, Xiaosha; Sun, Jade; Glasser, Chad; Attie, Kenneth M.; Sherman, Matthew L.; Pandya, Susan S.; Weiss, Jared Journal: Cancer Issue: Volume 122:Issue 23(2016) Page Start: 3641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. Issue 1 (4th December 2019) Authors: Cohen, Ezra E. W.; Pishvaian, Michael J.; Shepard, Dale R.; Wang, Ding; Weiss, Jared; Johnson, Melissa L.; Chung, Christine H.; Chen, Ying; Huang, Bo; Davis, Craig B.; Toffalorio, Francesca; Thall, Aron; Powell, Steven F. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bevacizumab in adjuvant treatment of non-small-cell lung cancer. Issue 12 (December 2017) Authors: Weiss, Jared Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Biomarkers predictive of response to pembrolizumab in head and neck cancer. (7th December 2022) Authors: Pfister, David G.; Haddad, Robert I.; Worden, Francis P.; Weiss, Jared; Mehra, Ranee; Chow, Laura Q. M.; Liu, Stephen V.; Kang, Hyunseok; Saba, Nabil F.; Wirth, Lori J.; Sukari, Ammar; Massarelli, Erminia; Ayers, Mark; Albright, Andrew; Webber, Andrea L.; Mogg, Robin; Lunceford, Jared; Huang, Lin... Journal: Cancer medicine Issue: Volume 12:Number 6(2023) Page Start: 6603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗